Comment from 1Day Sooner

Summary: 1Day Sooner supports the FDA's vision for real-time clinical trials but argues that a technology gap currently excludes smaller, rural, and community health sites from participating. They propose that the FDA develop and maintain an open-source Clinical Trial Management System (CTMS) to provide the necessary infrastructure for these under-resourced sites to participate in AI-enabled trials.